How Healthcare Organizations Are Redefining Facilities as a Strategic Asset
Drawing on real-world healthcare examples, the paper shows how facilities, energy systems, and digital tools can help strengthen resilience, improve efficiency, and support long-term financial sustainability.Key insights include:How proactive facility strategies can reduce downtime and support continuity of care Ways energy and infrastructure investments can improve reliability and lower operating costs How digital tools, automation, […]
Quick-Start Guide: Get Audit-Ready for CMS-0057 Enforcement
The final enforcement of rules around healthcare data exchange and prior authorizations is coming soon. The CMS Interoperability and Prior Authorization Final Rule (CMS-0057) begins on January 1, 2027 — meaning it’s time for API execution. But developing the required APIs isn’t enough to meet the requirements. CMS expects additional behind-the-scenes validation and payers that […]
Checkout is Now a Loyalty Strategy
Consumers have more ways than ever to check out and pay. And they have strong opinions about how they want to do it.The takeaway – checkout has become a make-or-break brand moment.But while consumers increasingly favor self-service, digital payments and frictionless experiences, many retail and hospitality organizations still rely on fragmented systems and legacy infrastructure.Based […]
Why Improving Trial Delivery Starts with Protocol Design
The protocol is singularly the most important document in the clinical development process. It is the blueprint that helps align investigators, study teams, institutional review boards, regulatory experts, and other stakeholders — and drives downstream activities. That’s why experts on protocol design and clinical operations say problems that arise later in clinical trials could have […]
5 Outpatient Planning Mistakes to Avoid
Outpatient growth strategies don’t typically fail because of clinical execution. More often, challenges begin earlier when key assumptions about demand, volume, and site-of-care go untested during the planning phase. This guide offers a practical lens to identify hidden risks, refine planning assumptions, and build strategies that are not only ambitious, but grounded, resilient, and financially […]
AI Deployment for Real – CI&T Executive Summary
CI&T has transformed AI from incremental productivity into exponential, measurable delivery at enterprise scale. Across 11 production deployments spanning financial services, insurance, retail, healthcare, and beyond, we’ve achieved dramatic cost reductions, delivery acceleration, and efficiency gains that fundamentally change software economics.Powered by CI&T FLOW, our Enterprise AI Management System, we’ve proven that orchestrating AI agents […]
Inside the World of Cell Therapies
Cell therapy has evolved from experimental treatment to established cancer care, with developers pursuing next-generation approaches and applications beyond oncology. Yet manufacturing complexities and investment pressures are reshaping the commercial landscape, forcing strategic recalibration across the sector.
From Uncertainty to Confidence: How a Disciplined Investment Process Helps Sustain Ministry
Take a look at how Wespath partners with institutional investors and faith-based organizations to design customized, values-aligned portfolios that support both today’s spending needs and long-term sustainability.This piece walks through key concepts every institutional investor should understand, including diversification, asset allocation, liquidity, risk tolerance and values alignment. It then explains Wespath’s three-phase process: a learning […]
Inside the future of patient engagement
Want to know what pharma leaders are saying about AI when they’re not on stage?Infinitus interviewed executives from 14 organizations, including Regeneron, Boehringer Ingelheim, Optum Rx, Amazon Pharmacy, and more. In this report, they share candid perspectives on AI, patient experience, workforce transformation, and what’s coming next.Read now for:Practical lessons for improving patient experience, transforming […]
Translating Obesity Research to De-Risk Future GLP-1 Trials
The GLP-1 anti-obesity drug class has matured and the disease areas in which its therapeutic potential is being investigated has expanded. This shift adds to research complexity and has implications for patient recruitment. Obesity trials will increasingly require an integrated approach to protocol design, recruitment and patient support.This playbook explores patient-centric strategies that drug developers […]